carmot glp 1 Therapeutics patents new GLP-1R agonists GLP-1 boom causing pharma FOMO

Discontinuing GLP-1 drug treatment leads to weight regain in a majority of patients.(28) Yet many stop using the medications even after losing significant weight

Therefore, from the maximum dose of 15mg, the patient stays on this dose for 4 weeks, then gets reduced to 12.5mg, then 10mg, then 7.5mg, then 5mg, then 2.5mg for 4 weeks, and then stops treatment

Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats

Clinically, T deficiency is correlated with increased fat mass, reduced insulin sensitivity, impaired glucose tolerance, and elevated triglyceride and total cholesterol [11]

We focused the survey and subsequent analysis on primarily six drug varieties

Smooth on boarding process